Therapeutic potential of HSP90 inhibition for neurofibromatosis type 2.
Tanaka K, Eskin A, Chareyre F, Jessen WJ, Manent J, Niwa-Kawakita M, Chen R, White CH, Vitte J, Jaffer ZM, Nelson SF, Rubenstein AE, Giovannini M.
Tanaka K, et al. Among authors: chareyre f.
Clin Cancer Res. 2013 Jul 15;19(14):3856-70. doi: 10.1158/1078-0432.CCR-12-3167. Epub 2013 May 28.
Clin Cancer Res. 2013.
PMID: 23714726
Free PMC article.